A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United States

BACKGROUND: The National Comprehensive Cancer Network recommends that patients with hormone receptor-positive early breast cancer be considered for adjuvant endocrine therapy (ET) after primary treatment like surgical excision. Adjuvant chemotherapy (CT) use primarily depends on risk of recurrence....

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Jacqueline, Scardo, Savannah, Method, Michael, Schlauch, Dan, Misch, Amanda, Picard, Shaita, Hamilton, Erika, Jones, Suzanne, Burris, Howard, Spigel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074265/
https://www.ncbi.nlm.nih.gov/pubmed/35524219
http://dx.doi.org/10.1186/s12885-022-09557-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074265/
https://www.ncbi.nlm.nih.gov/pubmed/35524219
http://dx.doi.org/10.1186/s12885-022-09557-6

Ejemplares similares